Rankings
▼
Calendar
CPRX Q1 2021 Earnings — Catalyst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
CPRX
Catalyst Pharmaceuticals, Inc.
$3B
Q1 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$30M
+3.7% YoY
Gross Profit
$26M
84.5% margin
Operating Income
$10M
32.4% margin
Net Income
$8M
25.4% margin
EPS (Diluted)
$0.07
QoQ Revenue Growth
-2.6%
Cash Flow
Operating Cash Flow
$4M
Free Cash Flow
$3M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$197M
Total Liabilities
$19M
Stockholders' Equity
$179M
Cash & Equivalents
$127M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$30M
$29M
+3.7%
Gross Profit
$26M
$25M
+2.2%
Operating Income
$10M
$11M
-8.4%
Net Income
$8M
$10M
-26.5%
← FY 2021
All Quarters
Q2 2021 →